LexDanaLexDanabeta
Inventor

Scott A. OAKES

Inventor
US

Overview

2→
Patents
2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
11,649,237Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition202311,613,544Substituted imidazo[1,5-a]pyrazines for modulation of IRE12023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to UNIV CALIFORNIA (2)· patent assignee history
2023Patents assigned to OPTIKIRA LLC (1)· patent assignee history
2023Patents assigned to UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (1)· patent assignee history
2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV CALIFORNIA22023
OPTIKIRA LLC12023
UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION12023
Locations
LocationPatentsSpan
US22023